Interactive Strength Inc. (Nasdaq:TRNR) Announces 1-for-10 Reverse Split

February 20, 2026 9:00 AM

Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or the "Company"), maker of innovative specialty fitness equipment under the Wattbike, CLMBR and FORME brands, today announced that it will conduct a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-10. The reverse stock split will become effective on February 24, 2026. The Company's common stock will begin trading on a post-split basis at the market open on...

Read more

CVS Pharmacy Partners with U.S. Soccer Federation and National Women's Soccer League to Promote Community Health and Wellness

February 20, 2026 9:00 AM

Building on its relationship with the Washington Spirit, CVS expands its commitment to soccer through a new multi-year sponsorship with the league and federation, which includes a national community field investment and partnering with the Kansas City Current and Seattle Reign FCOriginally published on CVS Health Company NewsCVS Pharmacy® has furthered its commitment to improving community health by becoming an Official Health and Wellness...

Read more

CORRECTION FROM SOURCE: The Nomination Committee's Proposal for New Board Members

February 20, 2026 8:48 AM

XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - Correction: In the press release that was distributed today at 2:00 p.m. CET, the nomination committee's proposal that Göran Dellgren should be nominated for re-election was missing. Below is the updated proposal from the nomination committee, including the addition that Göran Dellgren is proposed for re-election.Ahead of the Annual General Meeting to be held on 27 April 2026, the Nomination...

Read more

The Nomination Committee of XVIVO Perfusion AB (publ) Proposes Emil Billbäck and Anne-Karen Hunt as New Members of the Board of Directors

February 20, 2026 8:15 AM

XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV)Ahead of the Annual General Meeting to be held on 27 April 2026, the Nomination Committee proposes the re-election of Gösta Johannesson, Camilla Öberg, Erik Strömqvist and Paul Marcun, and the election of Emil Billbäck and Anne-Karen Hunt as new members of the Board of Directors. Lars Henriksson and Lena Höglund have declined re-election.Emil Billbäck has more than 30 years of experience in the...

Read more

Aspire Biopharma Regains Full Compliance with Nasdaq Listing Requirements

February 20, 2026 8:00 AM

Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), a biopharmaceutical company developing multi-faceted patent-pending drug delivery technology, today announced that it had received a notification letter from The Nasdaq Stock Market LLC ("Nasdaq") confirming that the Company has regained compliance with the minimum stockholders' equity threshold of $2.5 million under Listing Rule 5550(b)(1). The Company announced on...

Read more

Waystar Rated #1 Overall in Black Book's Q1 2026 Agentic and Generative AI Revenue Cycle Management Benchmark

February 20, 2026 8:00 AM

Black Book Market Research LLC today announced the availability of its 2026 report, "Revenue Cycle Management Agentic & Generative AI Benchmark: Qualitative KPI Performance, Governance, and Outcomes," an independent benchmarking study measuring client-reported performance of agentic AI-enabled revenue cycle management (RCM) solutions used by hospitals and medical groups.Fielded in two waves spanning Q4 2025 and Q1 2026, the study captures...

Read more

Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 26, 2026

February 20, 2026 6:00 AM

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its fourth quarter of 2025 ended December 31, 2025, after the market closes on Thursday, February 26, 2026, and will hold a conference call to discuss its financial results at 2:00 p.m. Pacific Time.To access the conference call, dial toll-free 877-407-0989, for international calls, dial 201-389-0921, ten minutes before the conference.The call can...

Read more

IRLAB has Received Scientific Advisory Board Confirmation on Next Steps for Pirepemat

February 20, 2026 1:20 AM

IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA), a company discovering and developing novel treatments for Parkinson's disease, today announced that its scientific advisory board has provided important guidance on the continued development and plans for its drug candidate, pirepemat. The advisory board concludes that the pharmacological rationale for pirepemat is sensible and that the reduction in falls observed in the Phase IIb trial is clinically...

Read more

Cantargia Publishes Full Year Report 2025

February 20, 2026 1:15 AM

Cantargia AB's (publ) ("Cantargia") (Nasdaq Stockholm:CANTA)(STO:CANTA) full year report for 2025 is now available on the company's web page www.cantargia.com/en/investors/financial-reports."Cantargia has completed a transformational year in a position of considerable strength. The combination of our Otsuka partnership, FDA Fast Track Designation, extended patent protection, compelling clinical data in PDAC patients with high IL1RAP expression,...

Read more

Diversatek Healthcare Expands BullDog Portfolio with New Disposable Bronchoscope Valves

February 19, 2026 11:00 AM

Diversatek Healthcare, a provider of gastrointestinal devices and diagnostic testing systems, proudly expands its proven BullDog® single-use valve portfolio with the launch of the BullDog® Disposable Bronchoscope Valves. The BullDog Disposable Bronchoscope Valves are conveniently packaged as a two-piece set, including a suction valve and biopsy valve. The suction valve is engineered for responsive actuation to deliver consistent suction,...

Read more

Management Change at XVIVO - CFO Transitions to New Role

February 19, 2026 11:00 AM

XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - XVIVO Perfusion AB (publ) today announces that the company's CFO, Kristoffer Nordström, has been appointed Senior Vice President Corporate Strategy & Business Development, effective April 1, 2026. He will continue to be a member of XVIVO's Executive Management Team.Senior Vice President Corporate Strategy & Business Development is a newly established global role with a particular focus on the...

Read more

Medical Care Technologies (OTC PINK:MDCE) Provides Corporate Update on Snapshot Recipes iOS Approval, Subscription Review and Multi-Platform Expansion

February 19, 2026 9:30 AM

Medical Care Technologies Inc. (OTC PINK:MDCE) today provided shareholders with a strategic update regarding the Company's first AI-based mobile application, Snapshot Recipes (www.snapshotrecipes.app).The application has been formally approved by the Apple iOS App Store and is currently live in testing mode. The Company is now awaiting final approval of its monthly and annual subscription offerings, which are typically processed within 24-48...

Read more

CVS Health Collaborates With Ronald McDonald House To Bring Holiday Cheer to Families

February 19, 2026 9:00 AM

Originally published on CVS HealthCVS Health® recently worked with Ronald McDonald House® Global to support families during their children's medical journeys during the holiday season. On December 3, the company collaborated with Philadelphia home decor creator Meghan Gallagher to decorate the first-ever Ronald McDonald House in Philadelphia with seasonal products from Joyward™, a new collection of decor, gifts and more just introduced by CVS...

Read more

Aspire Biopharma's Buzz Bomb Caffeine Company Names ChicExecs as Public Relations Agency of Record

February 19, 2026 8:00 AM

Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company") today announced that its wholly owned subsidiary Buzz Bomb Caffeine Company - marketer of a proprietary caffeine supplement - has named ChicExecs as its public relations agency of record.The appointment comes as BUZZ BOMB™ gears up for a transformative year focused on aggressive brand expansion, product innovation, and a refreshed market presence. ChicExecs, a powerhouse...

Read more

Applying Rural Health Transformation Program Funds Can Support Financial Sustainability for Rural Hospitals

February 19, 2026 8:00 AM

Rural hospitals now have a once-in-a-generation opportunity to strengthen both care delivery and long-term financial stability through new federal transformation dollars. As states begin implementing the Rural Health Transformation Program (RHTP), rural providers will have opportunities to align initiatives that support sustainability, modernization, and readiness for evolving payment models.One area of growing importance within rural...

Read more

Healthcare IT Capital Signals 2026: Deal Teams Double Down on "AI That Ships" and Put Cyber + Interoperability on the Term Sheet

February 19, 2026 7:45 AM

Black Book Research today announced the release of Healthcare IT Capital Signals 2026: What VCs, PE and Banks Are Underwriting, a new market intelligence report that quantifies where healthcare capital is moving in 2026, and why. The report synthesizes a pulse survey of healthcare investors, bankers, strategics, and healthcare technology innovators to surface the underwriting "must-haves" now defining fundraising success, M&A readiness, and...

Read more

Biodexa Licenses Phase 1 Ready Drug Candidate from Otsuka for Rare Stomach Cancer

February 19, 2026 7:30 AM

Biodexa Pharmaceuticals PLC (NASDAQ:BDRX), a clinical-stage biopharmaceutical company developing a pipeline of innovative products for the treatment of rare diseases with an increasing focus on products to treat or prevent gastrointestinal cancers, has added a new Phase 1 ready candidate to its portfolio, this time to target gastrointestinal stromal tumors, or GIST. Several drugs are available to treat GIST, but all ultimately fail when the...

Read more

Moderna to Present at Upcoming Conferences in March 2026

February 19, 2026 7:00 AM

Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conferences:TD Cowen 46th Annual Healthcare Conference, on Tuesday, March 3rd at 1:50pm ETBarclays 28th Annual Global Healthcare Conference, on Tuesday, March 10th at 9:30am ETA live webcast of each of these presentations will be available under "Events and Presentations" in the Investors section of the Moderna website at investors.modernatx.com.A...

Read more

Senzime Launches TetraCom Connectivity Platform Enabling Universal Transmission of Anesthesia Data

February 19, 2026 3:20 AM

Senzime AB (publ) (STO:SEZI)(OTCQX:SNZZF) today announced the launch of the TetraCom TM hospital connectivity platform. TetraCom is a first of its kind platform, enabling universal transmission of neuromuscular data directly into leading hospital enterprise systems such as Epic and Oracle Health (Cerner).TetraCom™ is a unique connectivity platform designed to seamlessly transmit real-time data from the Senzime TetraGraph ® neuromuscular monitor...

Read more

iZafe Group AB has Resolved on a Directed Share Issue of Class B Shares of Approximately SEK 19.8 Million in Order to Accelerate the Pace of Sales and Installations

February 19, 2026 3:00 AM

The Board of Directors of iZafe Group AB ("iZafe" or the "Company")(STO:IZAFE-B) has today (i) resolved to carry out a directed share issue of 20,868,973 class B shares pursuant to the authorization granted by the Annual General Meeting held on 28 May 2025, and (ii) resolved on a directed share issue of 39,236,014 class B shares, subject to subsequent approval by an Extraordinary General Meeting (together, the "Directed Share Issues"). Notice of...

Read more